Skip to content

SALIX PHARMACEUTICALS LTD

CIK 0001009356

← back to feed
Revenue (TTM)
$1.37B
−96.1% YoY FY Feb 2015
Net Income (TTM)
−$75.42M
−208.9% YoY FY Feb 2015
EPS Diluted (TTM)
−$1.22
−208.9% YoY FY Feb 2015
Gross Margin
74.4%
FY Feb 2015
Operating Margin
1.4%
FY Feb 2015
Net Margin
-5.5%
FY Feb 2015
Free Cash Flow (TTM)
$235.52M
FY Feb 2015
Cash
$499.34M
FY Feb 2015
Total Debt
$2.29B
FY Feb 2015
Shares Outstanding
64.25M sh
FY Feb 2015

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings